Suri Anish 4
4 · Cue Biopharma, Inc. · Filed Jul 25, 2023
Insider Transaction Report
Form 4
Suri Anish
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2023-07-21+124,125→ 124,125 totalExercise: $4.20Exp: 2033-07-20→ Common Stock (124,125 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023.